N
NVO

Nuveen’s Novo Nordisk NVO Stock Holding History

Nuveen’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,095,758
Closed -$145M – 3291
2025
Q2 		$145M Sell
2,095,758
-3,236,504
-61% -$220M 0.04% 311
2025
Q1 		$370M Sell
5,332,262
-912,669
-15% -$75.4M 0.11% 161
2024
Q4 		$537M Buy
6,244,931
+2,639,693
+73% +$285M 0.15% 116
2024
Q3 		$429M Buy
3,605,238
+86,242
+2% +$11.5M 0.12% 146
2024
Q2 		$502M Sell
3,518,996
-153,290
-4% -$20.3M 0.15% 120
2024
Q1 		$472M Buy
3,672,286
+525,211
+17% +$62.5M 0.14% 131
2023
Q4 		$326M Sell
3,147,075
-41,389
-1% -$4.09M 0.1% 170
2023
Q3 		$290M Buy
3,188,464
+22,982
+0.7% +$2.02M 0.1% 180
2023
Q2 		$256M Buy
3,165,482
+850,078
+37% +$69.4M 0.09% 184
2023
Q1 		$184M Buy
2,315,404
+933,614
+68% +$66.2M 0.07% 243
2022
Q4 		$93.5M Buy
+1,381,790
New +$81M 0.04% 378
2022
Q1 		– Sell
-113,654
Closed -$6.37M – 3411
2021
Q4 		$6.37M Sell
113,654
-27,254
-19% -$1.48M ﹤0.01% 1973
2021
Q3 		$6.76M Sell
140,908
-6
-0% -$290 ﹤0.01% 2055
2021
Q2 		$5.9M Hold
140,914
– – ﹤0.01% 2164
2021
Q1 		$4.75M Buy
140,914
+646
+0.5% +$23K ﹤0.01% 2197
2020
Q4 		$4.9M Sell
140,268
-362
-0.3% -$12.5K ﹤0.01% 2089
2020
Q3 		$4.88M Sell
140,630
-434
-0.3% -$14.5K ﹤0.01% 1925
2020
Q2 		$4.62M Sell
141,064
-538
-0.4% -$17.2K ﹤0.01% 1937
2020
Q1 		$4.26M Sell
141,602
-272
-0.2% -$8.1K ﹤0.01% 1804
2019
Q4 		$4.11M Buy
+141,874
New +$3.93M ﹤0.01% 2093

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's NVO Position: Q3 2025 in Review

Nuveen sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 2,095,758 shares — an estimated $145M sold.

Nuveen first reported a position in NVO in Q4 2019 and held it in 20 quarters. The position peaked at $537M in Q4 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Nuveen reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Nuveen sold 2,095,758 Novo Nordisk shares in Q3 2025, an estimated $145M.
  • Nuveen first reported a position in Novo Nordisk in Q4 2019 and held it in 20 quarters.
  • Nuveen's Novo Nordisk position peaked at $537M in Q4 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.